Literature DB >> 17477351

Methylation suppresses the proteasome-inhibitory function of green tea polyphenols.

Kristin R Landis-Piwowar1, Sheng Biao Wan, Richard A Wiegand, Deborah J Kuhn, Tak Hang Chan, Q Ping Dou.   

Abstract

Under physiological conditions, biotransformation reactions, such as methylation, can modify green tea polyphenols (GTPs) and therefore limit their in vivo cancer-preventive activity. Although a recent study suggested that methylated polyphenols are less cancer-protective, the molecular basis is unknown. We previously reported that ester bond-containing GTPs, for example (-)-epigallocatechin-3-gallate [(-)-EGCG] or (-)-epicatechin-3-gallate [(-)-ECG], potently and specifically inhibit the proteasomal chymotrypsin-like activity. In this study, we hypothesize that methylated GTPs have decreased proteasome-inhibitory abilities. To test this hypothesis, methylated (-)-EGCG and (-)-ECG analogs that can be found in vivo were synthesized and studied for their structure-activity relationships (SARs) using a purified 20S proteasome. The addition of a single methyl group on (-)-EGCG or (-)-ECG led to decreased proteasome inhibition and, as the number of methyl groups increased, the inhibitory potencies further decreased. These SARs were supported by our findings from in silico docking analysis published recently. Previously, we synthesized a peracetate-protected (-)-EGCG molecule, Pro-EGCG (1), to enhance its cellular permeability and stability, and current HPLC analysis confirms conversion of Pro-EGCG (1) to (-)-EGCG in cultured human leukemic Jurkat T cells. Furthermore, in this study, peracetate-protected forms of methylated GTPs were added in intact Jurkat T cells to observe the intracellular effects of methylation. Peracetate-protected, monomethylated (-)-EGCG induced greater cellular proteasome inhibition and apoptosis than did peracetate-protected, trimethylated (-)-EGCG, consistent with the potencies of the parent methylated analogs against a purified 20S proteasome. Therefore, methylation on GTPs, under physiological conditions, could decrease their proteasome-inhibitory activity, contributing to decreased cancer-preventive effects of tea consumption. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17477351     DOI: 10.1002/jcp.21124

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  29 in total

Review 1.  Targeting tumor ubiquitin-proteasome pathway with polyphenols for chemosensitization.

Authors:  Min Shen; Tak Hang Chan; Q Ping Dou
Journal:  Anticancer Agents Med Chem       Date:  2012-10-01       Impact factor: 2.505

2.  Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention.

Authors:  Piwen Wang; William J Aronson; Min Huang; Yanjun Zhang; Ru-Po Lee; David Heber; Susanne M Henning
Journal:  Cancer Prev Res (Phila)       Date:  2010-07-13

Review 3.  Tea and human health: biomedical functions of tea active components and current issues.

Authors:  Zong-mao Chen; Zhi Lin
Journal:  J Zhejiang Univ Sci B       Date:  2015-02       Impact factor: 3.066

4.  Green Tea Polyphenols in drug discovery - a success or failure?

Authors:  Thomas J Smith
Journal:  Expert Opin Drug Discov       Date:  2011-06       Impact factor: 6.098

Review 5.  Epigenetic effects of green tea polyphenols in cancer.

Authors:  Susanne M Henning; Piwen Wang; Catherine L Carpenter; David Heber
Journal:  Epigenomics       Date:  2013-12       Impact factor: 4.778

6.  Prevention of hepatitis C virus infection using a broad cross-neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate.

Authors:  Daire O'Shea; John Law; Adrian Egli; Donna Douglas; Gary Lund; Sarah Forester; Joshua Lambert; Mansun Law; Dennis R Burton; D L J Tyrrell; Michael Houghton; Atul Humar; Norman Kneteman
Journal:  Liver Transpl       Date:  2016-01-29       Impact factor: 5.799

Review 7.  The challenge of developing green tea polyphenols as therapeutic agents.

Authors:  C Huo; S B Wan; W H Lam; L Li; Z Wang; K R Landis-Piwowar; D Chen; Q P Dou; T H Chan
Journal:  Inflammopharmacology       Date:  2008-10       Impact factor: 4.473

Review 8.  Green tea polyphenols as a natural tumour cell proteasome inhibitor.

Authors:  Q P Dou; K R Landis-Piwowar; D Chen; C Huo; S B Wan; T H Chan
Journal:  Inflammopharmacology       Date:  2008-10       Impact factor: 4.473

9.  Antitumor activity of novel fluoro-substituted (-)-epigallocatechin-3-gallate analogs.

Authors:  Huanjie Yang; Dong Kui Sun; Di Chen; Qiuzhi Cindy Cui; Yan Yan Gu; Tao Jiang; Wei Chen; Sheng Biao Wan; Q Ping Dou
Journal:  Cancer Lett       Date:  2009-12-03       Impact factor: 8.679

10.  Prodrugs of fluoro-substituted benzoates of EGC as tumor cellular proteasome inhibitors and apoptosis inducers.

Authors:  Zhiyong Yu; Xu Long Qin; Yan Yan Gu; Di Chen; Qiuzhi Cindy Cui; Tao Jiang; Sheng Biao Wan; Q Ping Dou
Journal:  Int J Mol Sci       Date:  2008-06-02       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.